Skip to main content

Advertisement

SpringerLink
Log in

Effect of Prolonged GnRH Agonist Downregulation on ICSI Outcome in Patients With Endometriomas of Less Than 5 cm: A Randomized Controlled Trial

  • Original Article
  • Published:
Reproductive Sciences Aims and scope Submit manuscript

Abstract

Objective:To evaluate the effect of prolonged Gonadotropin releasing hormone (GnRH) agonist downregulation in patients with endometriomas of less than 5 cm on the outcome of the proceeding Intracytoplasmic sperm injection (ICSI) trial. Methods: In a randomized controlled trial at a university teaching hospital, 90 patients indicated for ICSI and having unilateral single endometrioma of less than 5 cm in diameter were randomized into 2 groups. Group A (45 patients) received the standard long protocol; whereas group B (45 patients) received 3 consecutive Intramuscular (IM) injections of triptorelin 3.75 mg 28 days apart followed by the standard long protocol 28 days after the last injection. Results: There were no significant differences in the clinical and hormonal characteristics between the 2 groups. All ICSI cycle characteristics including number of retrieved oocytes, fertilized oocytes, and transferred embryos were also not significantly different. However, patients who received prolonged GnRH agonist therapy showed significantly higher chemical (P = .011), clinical (P = .018), and ongoing (P = .028) pregnancy rates. Conclusion: Prolonged GnRH agonist downregulation improves the pregnancy rates in patients with small endometriomas undergoing ICSI.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ozkan S, Murk W, Arici A. Endometriosis and infertility: epidemiology and evidence-based treatments. Ann N Y Acad Sci. 2008; 1127:92–100.

    Article  Google Scholar 

  2. Redwine DB. Ovarian endometriosis: a marker for more extensive pelvic and intestinal disease. Fertil Steril. 1999;72(2):310–315.

    Article  CAS  Google Scholar 

  3. Donnez J, Nisolle M, Gillet N, Smets M, Bassil S, Casanas-Roux F. Large ovarian endometriomas. Hum Reprod. 1996; 11(3):641–646.

    Article  CAS  Google Scholar 

  4. Young VJ, Brown JK, Saunders PT, Horne AW. The role of the peritoneum in the pathogenesis of endometriosis. Hum Reprod Update. 2013;19(5):558–569.

    Article  Google Scholar 

  5. Pellicer A, Albert C, Mercader A, Bonilla-Musoles F, Remohi J, Simon C. The follicular and endocrine environment in women with endometriosis: local and systemic cytokine production. Fertil Steril. 1998;70(3):425–431.

    Article  CAS  Google Scholar 

  6. Wu HN, Wu MY, Yang YS. Peritoneal cellular immunity and endometriosis. Am J Reprod Immunol. 1997;38(6):400–412.

    Article  Google Scholar 

  7. Carlberg M, Nejaty J, Froysa B, Guan Y, Soder O, Bergqvist A. Elevated expression of tumor necrosis factor alpha in cultured granulosa cells from women with endometriosis. Human Reprod. 2000;15(6):1250–1255.

    Article  CAS  Google Scholar 

  8. Toya M, Saito H, Ohta N, Saito T, Kaneko T, Hiroi M. Moderate and sever endometriosis is associated with alterations in the cell cycle of granulosa cells in patients undergoing in vitro fertilization and embryo transfer. Fertil Steril. 2000;73(2):344–350.

    Article  CAS  Google Scholar 

  9. Senturk LM, Arici A. Immunology of endometriosis. J Reprod Immunol. 1999;43(1);67–83.

    Article  CAS  Google Scholar 

  10. Pellicer A, Valbuena D, Bauset C, et al. The follicular endocrine environment in stimulated cycles of women with endometriosis: steroid levels and embryo quality. Fertil Steril. 1998; 69(6):1135–1141.

    Article  CAS  Google Scholar 

  11. Smith MP, Keay SD, Margo FC, et al. Total cortisol levels are reduced in the preovulatory follicle of infertile women with minimalmild endometriosis. Am J Reprod Immunol. 2002; 47(1):52–56.

    Article  CAS  Google Scholar 

  12. Sanchez AM, Vigano P, Somigliana E, Panina-Bordignon P, Vercellini P, Candiani M. The distinguishing cellular and molecular features of the endometriotic ovarian cyst: from pathophysiology to the potential endometrioma-mediated damage to the ovary. Hum Reprod Update. 2014;20(2):217–230.

    Article  CAS  Google Scholar 

  13. Hamdan M, Dunselman G, Li TC, Cheong Y. The impact of endometrioma on IVF/ICSI outcomes: a systematic review and meta-analysis. Hum Reprod Update. 2015;21(6):809–825.

    Article  CAS  Google Scholar 

  14. Gupta S, Agarwal A, Agarwal R, Loret de Mola JR. Impact of ovarian endometrioma on assisted reproduction outcomes. Reprod Biomed Online. 2006;13(3):349–360.

    Article  Google Scholar 

  15. Arici A, Oral E, Bukulmez O, Duleba A, Olive DL, Jones EE. The effect of endometriosis on implantation: results from the Yale University in vitro fertilization and embryo transfer program. Fertil Steril. 1996;65(3):603–607.

    Article  CAS  Google Scholar 

  16. Huang A, Hunter M, DeCherney AH. Endometriosis and ART. In: Gardner DK, Weissman A, Howles CM, Shoham Z, eds. Textbook of Assisted Reproductive Technologies. 3rd ed. United Kingdom: Informa; 2009.

    Google Scholar 

  17. Surrey ES. Endometriosis-related infertility: the role of the assisted reproductive technologies. Biomed Res Int. 2015;2015: 482959.

    Article  Google Scholar 

  18. Dunselman GA1, Vermeulen N, Becker C. European Society of Human Reproduction and Embryology. ESHRE guideline: management of women with endometriosis. Hum Reprod. 2014 Mar; 29(3):400–412. doi: 10.1093/humrep/det457. Epub 2014 Jan 15.

    Article  CAS  Google Scholar 

  19. Barnhart K, Dunsmoor-Su R, Coutifaris C. Effect of endometriosis on in vitro fertilization. Fertil Steril. 2002; 77(6):1148–1155.

    Article  Google Scholar 

  20. Kuivasaari P, Hippelainnen M, Anttila M, Heinonen S. Effect of endometriosis on IVF/ICSI outcome: stage III/IV endometriosis worsens cumulative pregnancy and live-born rates. Hum Reprod. 2005;20(11):3130–3135.

    Article  Google Scholar 

  21. Dlugi AM, Loy RA, Dieterle S, Bayer SR, Seibel MM. The effect of endometriosis on in vitro fertilization outcome. J In Vitro Fert Embryo Transf. 1989;6(6):338–341.

    Article  CAS  Google Scholar 

  22. Somigliana E, Infantino M, Benedetti F, et al. The presence of ovarian endometriomas is associated with reduced responsiveness to gonadotropins. Fertil Steril. 2006;86(1):192–196.

    Article  CAS  Google Scholar 

  23. Yanushpolsky EH, Best CL, Jackson KV, et al. Effects of endo-metriomas on oocyte quality, embryo quality, and pregnancy rates in in vitro fertilization cycles: a prospective, case-controlled study. J Assist Reprod Genet. 1998;15(4):193–197.

    Article  CAS  Google Scholar 

  24. Van Holsbeke C, van Calster B, Guerriero S, et al. Endometriomas: their ultrasound characteristics. Ultrasound Obstet Gynecol. 2010;35(6):730–740.

    PubMed  Google Scholar 

  25. Vladareanu R, Andrei Ch, Zvanca M. Newer developments in ultrasound in infertility. In: Kurjak A, Chervenak FA, eds. Donald School Textbook of Ultrasound in Obstetrics and Gynecology. 3rd ed. India: Jaypee Brothers Medical Publishers(P) Ltd; 2011.

    Google Scholar 

  26. Papanikolaou E, D’haeseleer E, Verheyen G, et al. Live birth rate is significantly higher after blastocyst transfer when at least four embryos are available on day 3 of embryo culture. A randomized prospective study. Hum Reprod. 2005;20(11):3198–3203.

    Article  Google Scholar 

  27. Sallam HN, Garcia-Velasco JA, Dias S, Arici A. Long-term pituitary down-regulation before in vitro fertilization (IVF) for women with endometriosis. Cochrane Database Syst Rev. 2006;(1): CD004635.

    Google Scholar 

  28. Kim CH, Cho YK, Mok JE. Simplified ultralong protocol of gonadotropin releasing hormone agonist for ovulation induction with intrauterine insemination in patients with endometriosis. Hum Reprod. 1996;11(2):398–402.

    Article  CAS  Google Scholar 

  29. Dicker D, Goldman JA, Levy T, Feldberg D, Ashkenazi J. The impact of long-term gonadotropin releasing hormone analogue treatment on preclinical abortions in patients with severe endo-metriosis undergoing in vitro fertilization-embryo transfer. Fertil Steril. 1992;57(3):597–600.

    Article  CAS  Google Scholar 

  30. Rickes D, Nickel I, Kropf S, Kleinstein J. Increased pregnancy rates after ultralong postoperative therapy with gonadotropin releasing hormone analogues in patients with endometriosis. Fertil Steril. 2002;78(4):757–762.

    Article  Google Scholar 

  31. Surrey ES, Silverberg KM, Surrey MW, Schoolcraft WB. Effects of prolonged gonadotropin releasing hormone agonist therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis. Fertil Steril. 2002;78(4):699–704.

    Article  Google Scholar 

  32. Nakamura K, Oosawa M, Kondou I, et al. Metrodin stimulation after prolonged gonadotropin releasing hormone agonist pretreat-ment for in vitro fertilization in patients with endometriosis. J Assist Reprod Genet. 1992;9(2):113–117.

    Article  CAS  Google Scholar 

  33. Chedid S, Camus M, Smitz J, et al. Comparison among different ovarian stimulation regimens for assisted reproduction procedures in patients with endometriosis. Hum Reprod. 1995; 10(9):2406–2411.

    Article  CAS  Google Scholar 

  34. Conn PM, Huckle WR, Andrews WV, et al. The molecular mechanism of action of gonadotropin releasing hormone (GnRH) in the pituitary. Recent Prog Horm Res. 1987;43:29–68.

    CAS  PubMed  Google Scholar 

  35. Meresman GF, Bilotas MA, Lombardi E, et al. Effect of GnRH analogues on apoptosis and release of interleukin-1b and vascular endothelial growth factor in endometrial cell cultures from patients with endometriosis. Hum Reprod. 2005;18(9):1767–1771.

    Article  Google Scholar 

  36. Lebovic DI, Bentzien F, Chao VA, et al. Introduction of an angiogenic phenotype in endometriotic stromal cell cultures by interleukin-1β. Mol Hum Reprod. 2000;6(3):269–275.

    Article  CAS  Google Scholar 

  37. Mc Laren J. Vascular endothelial growth factor (VEGF) and endo-metriotic angiogenesis. Hum Reprod Update. 2000;6(1):45–55.

    Article  CAS  Google Scholar 

  38. De la Fuente G, Garcia-Velasco JA. Ovarian endometriosis: effect on IVF outcome. In: Gardner DK, Rizk B, Falcone, eds. Human Assisted Reproductive Technology. New York: Cambridge University Press; 2011.

    Google Scholar 

  39. Nezhat F, Nezhat C, Allan CJ, Metzger DA, Sears DL. Clinical and histologic classification of endometriomas. Implications for a mechanism of pathogenesis. J Reprod Med. 1992;37(9):771–776.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics & Gynecology, Cairo University, 481 King Faisal Street, Haram, Giza, Egypt

    Ahmed Mohamed Maged MD, Hamsa Rashwan MD, Maryam Mahmoud MD, Akmal El-Mazny MD, Mona Farouk MD, Doaa S. Belal MD & Heba M. Marie MD

Authors
  1. Ahmed Mohamed Maged MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hamsa Rashwan MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Maryam Mahmoud MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Akmal El-Mazny MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mona Farouk MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Doaa S. Belal MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Heba M. Marie MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ahmed Mohamed Maged MD.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Maged, A.M., Rashwan, H., Mahmoud, M. et al. Effect of Prolonged GnRH Agonist Downregulation on ICSI Outcome in Patients With Endometriomas of Less Than 5 cm: A Randomized Controlled Trial. Reprod. Sci. 25, 1509–1514 (2018). https://doi.org/10.1177/1933719118756753

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1177/1933719118756753

Keywords

Search

Navigation